Advertisement
Screener

CalciMedica, Inc. (CALC) Other

CalciMedica, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2025-11-12: Form 10-Q; Item Emerging growth company; As filed Yes.
  • 2025-08-12: Form 10-Q; Item Emerging growth company; As filed Yes.
  • 2025-05-14: Form 10-Q; Item Emerging growth company; As filed Yes.
  • 2025-03-27: Form 10-K; Item Emerging growth company; As filed Yes.
FiledFormItemAs filed
2025-11-1210-QEmerging growth companyYes
2025-08-1210-QEmerging growth companyYes
2025-05-1410-QEmerging growth companyYes
2025-03-2710-KEmerging growth companyYes
2024-11-1310-QEmerging growth companyYes
2024-08-1210-QEmerging growth companyYes
2024-05-1310-QEmerging growth companyYes
2024-04-2910-K/AEmerging growth companyYes
2024-03-2810-KEmerging growth companyYes
2023-11-0910-QEmerging growth companyYes
2023-08-1110-QEmerging growth companyYes
2023-05-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CALC
2023-05-1210-QEmerging growth companyYes
2023-04-0410-K/AStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CALC
2023-04-0410-K/AEmerging growth companyYes
2023-03-0910-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · The Nasdaq Global Market
2023-03-0910-KEmerging growth companyYes
2022-11-1010-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · The Nasdaq Global Market
2022-11-1010-QEmerging growth companyYes
2022-08-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · The Nasdaq Global Market
2022-08-1210-QEmerging growth companyYes
2022-05-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · The Nasdaq Global Market
2022-05-1210-QEmerging growth companyYes
2022-03-1110-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · The Nasdaq Global Market
2022-03-1110-KEmerging growth companyYes
2021-11-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · The Nasdaq Global Market
2021-11-1210-QEmerging growth companyYes
2021-08-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · The Nasdaq Global Market
2021-08-1210-QEmerging growth companyYes
2021-05-1410-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · NASDAQ
2021-05-1410-QEmerging growth companyYes
2021-03-0510-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · NASDAQ
2021-03-0510-KEmerging growth companyYes
2020-11-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · GRAY · NASDAQ
2020-11-1210-QEmerging growth companyYes
2020-11-1210-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
TALPHERA, INC. (TLPH)United States$0.060B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
HYPERION DEFI, INC. (HYPD)United States$0.065B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99